MARIE BENNETT: Open Payments
NPI 1215376405 · AYER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,935 in 114 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $218 · 2025 $2,935
Food & beverage: $2,850Education: $85
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $448 |
| Janssen Biotech, Inc. | 13 | $327 |
| ABBVIE INC. | 11 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $201 |
| Phathom Pharmaceuticals, Inc. | 10 | $199 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Madrigal Pharmaceuticals | 4 | $144 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Eisai Inc. | 1 | $122 |
| Aimmune Therapeutics, Inc. | 4 | $104 |
Products named: XIFAXAN, TREMFYA, VOQUEZNA, RINVOQ, AMVUTTRA, REZDIFFRA, ENTYVIO, AIRSUPRA.
Industry payments across MA — which companies pay providers there.
